These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22801423)

  • 1. Correlation between NS5A dimerization and hepatitis C virus replication.
    Lim PJ; Chatterji U; Cordek D; Sharma SD; Garcia-Rivera JA; Cameron CE; Lin K; Targett-Adams P; Gallay PA
    J Biol Chem; 2012 Aug; 287(36):30861-73. PubMed ID: 22801423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
    Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
    Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A.
    Sun JH; O'Boyle DR; Fridell RA; Langley DR; Wang C; Roberts SB; Nower P; Johnson BM; Moulin F; Nophsker MJ; Wang YK; Liu M; Rigat K; Tu Y; Hewawasam P; Kadow J; Meanwell NA; Cockett M; Lemm JA; Kramer M; Belema M; Gao M
    Nature; 2015 Nov; 527(7577):245-8. PubMed ID: 26536115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISGylation of Hepatitis C Virus NS5A Protein Promotes Viral RNA Replication via Recruitment of Cyclophilin A.
    Abe T; Minami N; Bawono RG; Matsui C; Deng L; Fukuhara T; Matsuura Y; Shoji I
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32727878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
    Chukkapalli V; Berger KL; Kelly SM; Thomas M; Deiters A; Randall G
    Virology; 2015 Feb; 476():168-179. PubMed ID: 25546252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the Disordered Domain II of Hepatitis C Virus NS5A with Cyclophilin A, NS5B, and Viral RNA Show Extensive Overlap.
    Ngure M; Issur M; Shkriabai N; Liu HW; Cosa G; Kvaratskhelia M; Götte M
    ACS Infect Dis; 2016 Nov; 2(11):839-851. PubMed ID: 27676132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of BMS-790052 on hepatitis C virus genotype 4 NS5A.
    Wang C; Jia L; Huang H; Qiu D; Valera L; Huang X; Sun JH; Nower PT; O'Boyle DR; Gao M; Fridell RA
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1588-90. PubMed ID: 22203595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein.
    Lee C; Ma H; Hang JQ; Leveque V; Sklan EH; Elazar M; Klumpp K; Glenn JS
    Virology; 2011 May; 414(1):10-8. PubMed ID: 21513964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy.
    Lee C
    Arch Pharm Res; 2011 Sep; 34(9):1403-7. PubMed ID: 21975800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
    Boson B; Denolly S; Turlure F; Chamot C; Dreux M; Cosset FL
    Gastroenterology; 2017 Mar; 152(4):895-907.e14. PubMed ID: 27932311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly.
    Appel N; Zayas M; Miller S; Krijnse-Locker J; Schaller T; Friebe P; Kallis S; Engel U; Bartenschlager R
    PLoS Pathog; 2008 Mar; 4(3):e1000035. PubMed ID: 18369481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.
    Scheel TK; Gottwein JM; Mikkelsen LS; Jensen TB; Bukh J
    Gastroenterology; 2011 Mar; 140(3):1032-42. PubMed ID: 21111742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophilin A allows the allosteric regulation of a structural motif in the disordered domain 2 of NS5A and thereby fine-tunes HCV RNA replication.
    Dujardin M; Madan V; Gandhi NS; Cantrelle FX; Launay H; Huvent I; Bartenschlager R; Lippens G; Hanoulle X
    J Biol Chem; 2019 Aug; 294(35):13171-13185. PubMed ID: 31315928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052.
    Fridell RA; Qiu D; Valera L; Wang C; Rose RE; Gao M
    J Virol; 2011 Jul; 85(14):7312-20. PubMed ID: 21593143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.
    Wang WT; Tsai TY; Chao CH; Lai BY; Wu Lee YH
    J Virol; 2015 Nov; 89(22):11584-602. PubMed ID: 26355086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation.
    Lim YS; Hwang SB
    J Biol Chem; 2011 Apr; 286(13):11290-8. PubMed ID: 21297162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
    Chatterji U; Lim P; Bobardt MD; Wieland S; Cordek DG; Vuagniaux G; Chisari F; Cameron CE; Targett-Adams P; Parkinson T; Gallay PA
    J Hepatol; 2010 Jul; 53(1):50-6. PubMed ID: 20451281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Proline-Tryptophan Turn in the Intrinsically Disordered Domain 2 of NS5A Protein Is Essential for Hepatitis C Virus RNA Replication.
    Dujardin M; Madan V; Montserret R; Ahuja P; Huvent I; Launay H; Leroy A; Bartenschlager R; Penin F; Lippens G; Hanoulle X
    J Biol Chem; 2015 Jul; 290(31):19104-20. PubMed ID: 26085105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A.
    Shanmugam S; Nichols AK; Saravanabalaji D; Welsch C; Yi M
    PLoS Pathog; 2018 Jul; 14(7):e1007177. PubMed ID: 30036383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.